D-0547-2026 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Bedminster, NJ

FDA drug recall D-0547-2026 was initiated by Ascend Laboratories, LLC on Apr 27, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 17,304 100-count bottles.

Recall details

Product Type
Drugs
Report Date
May 20, 2026
Initiation Date
Apr 27, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,304 100-count bottles

Product description

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

U.S. Nationwide

Code information

Lot # 25140859; Exp. Date: Jan 2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0547-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0547-2026. Report a data issue: hello@regdatalab.com.